Why the study?
Does a fixed combination of low dose nifedipine and acebutolol reduce blood pressure as effectively as standard dose acebutolol in patients with essential hypertension?
Does a fixed combination of low dose nifedipine and acebutolol reduce blood pressure as effectively as standard dose acebutolol in patients with essential hypertension?
A low-dose combination of nifedipine and acebutolol is as effective as standard-dose acebutolol in lowering blood pressure in essential hypertension, with similar tolerability.
Low-dose nifedipine-acebutolol combination matches standard-dose acebutolol for BP reduction; confirms equivalence in this essential hypertension RCT.
114 patients from four clinics participated in a double blind study designed to assess the efficacy of a nifedipine-acebutolol fixed combination -10 mg + 100 mg - as compared with acebutolol -200 mg- in essential hypertension. During the ten week study the mean blood pressure readings (s.d.) 1-3 h after treatment decreased from 179.2/104.8 (10.2/6.2) to 150.3/87.7 (9.8/7.7) in the combination group and from 181.7/106.5 (14.4/7.0) to 150.4/89.0 (15.0/10.4) in the acebutolol group. The mean systolic and diastolic blood pressures were also decreased after exertion (load) and 24 hours after treatment at the end of the 6th week of the study. A doubling of the dose from week 7 to 10 did not change these figures. These results reveal the possibility of treating essential hypertension with a low dose of beta-adrenergic blocking agents in combination with 10 mg nifedipine. Both drugs were well tolerated. 3 patients (5%) in the combination group and 3 patients in the acebutolol group were withdrawn from the study because of headache and dizziness.
No takes yet. Share an insight, caveat, or question.
Lejeune et al. (1985) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: